Pharmacokinetics, safety, and tolerability of a new patritumab formulation in patients with advanced, refractory solid tumors.

被引：4

作者：

Papadopoulos, Kyriakos P.

Moore, Kathleen N.

Lush, Richard

Desai, Madhuri

Mahmood, Syed

Beckman, Robert A.

Mendell-Harary, Jeanne

机构：

[1] START South Texas Accelerated Res Therapeut LLC, San Antonio, TX USA

[2] Peggy & Charles Stephenson Oklahoma Canc Ctr, Oklahoma City, OK USA

[3] H Lee Moffitt Canc Ctr & Res Inst Inc, Tampa, FL USA

[4] Daiichi Sankyo, Edison, NJ USA

[5] Georgetown Univ, Med Ctr, Washington, DC 20007 USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 15期

关键词：

D O I：

10.1200/jco.2015.33.15_suppl.e14026

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

e14026

引用

页数：1

共 50 条

[21] Safety and pharmacokinetics of panitumumab in Japanese patients with advanced solid tumors [J].

Doi, Toshihiko ;

Ohtsu, Atsushi ;

Tahara, Makoto ;

Tamura, Tomohide ;

Shirao, Kuniaki ;

Yamada, Yasuhide ;

Otani, Satoru ;

Yang, Bing-Bing ;

Ohkura, Masayuki ;

Ohtsu, Tomoko .

INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2009, 14 (04) :307-314

[22] Population pharmacokinetics of durvalumab and fixed dosing regimens in patients with advanced solid tumors. [J].

Baverel, Paul ;

Dubois, Vincent ;

Jin, Chaoyu ;

Song, Xuyang ;

Jin, Xiaoping ;

Mukhopadhyay, Pralay ;

Gupta, Ashok Kumar ;

Dennis, Phillip A. ;

Ben, Yong ;

Roskos, Lorin ;

Narwal, Rajesh .

JOURNAL OF CLINICAL ONCOLOGY, 2017, 35

[23] Phase I study of safety, tolerability, and pharmacokinetics of pazopanib in combination with oral topotecan in patients with advanced solid tumors [J].

Kerklaan, Bojana Milojkovic ;

Lolkema, Martijn P. J. K. ;

Devriese, Lot A. ;

Voest, Emile E. ;

Nol-Boekel, A. ;

Mergui-Roelvink, M. ;

Mykulowycz, Kristine ;

Stoebenau, Joseph E. ;

Fang, Lei ;

Legenne, Philippe ;

Wissel, Paul Stephen ;

Smith, Deborah A. ;

Giantonio, Bruce J. ;

Schellens, Jan H. M. ;

Witteveen, Petronella .

JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)

[24] Safety, tolerability, and pharmacokinetics of the OX40 agonist ABBV-368 in patients with advanced solid tumors [J].

Spira, A. ;

Chung, K. ;

Patnaik, A. ;

Tolcher, A. W. ;

Blaney, M. E. ;

Parikh, A. ;

Reddy, A. ;

Henner, W. ;

McDevitt, M. ;

Afar, D. ;

Powderly, J. .

ANNALS OF ONCOLOGY, 2018, 29

[25] A phase I study of the safety, tolerability, and pharmacokinetics of intravenous XMT-1001 in patients with advanced solid tumors [J].

Sausville, Edward A. ;

Anthony, Stephen P. ;

Garbo, Lawrence E. ;

Shkolny, Dana ;

Yurkovetskiy, Alex V. ;

Bethune, Claudette ;

Schwertschlag, Ullrich ;

Fram, Robert J. .

MOLECULAR CANCER THERAPEUTICS, 2007, 6 (12) :3383S-3383S

[26] Phase I safety and tolerability of once daily oral afatinib (A) in combination with gemcitabine (G) in patients with advanced solid tumors. [J].

Zanetta, Sylvie ;

Bennouna, Jaafar ;

Isambert, Nicolas ;

De-Montserrat, Helene ;

Squiban, Patrick J. ;

Delord, Jean-Pierre .

JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)

[27] A safety, tolerability, and pharmacokinetic (PK) study of GW572016 in patients with solid tumors. [J].

Pandite, L ;

Burris, HA ;

Jones, S ;

Wilding, G ;

Taylor, C ;

Versola, MJ ;

Smith, DA ;

Stead, A ;

Koch, KM ;

Spector, NL .

JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) :238S-238S

[28] Initial phase I trial of a new liposome-encapsulated doxorubicin formulation in patients with refractory solid tumors. [J].

Izquierdo, MA ;

Balañá, C ;

Fabregat, X ;

García, M ;

Martinez, M ;

Llorens, MA ;

Gimeno, M ;

Mesia, R ;

Rosell, R ;

Germá, JR .

CLINICAL CANCER RESEARCH, 1999, 5 :3795S-3795S

[29] Safety and tolerability of the olaparib tablet formulation in Japanese patients with advanced solid tumours [J].

Yonemori, Kan ;

Tamura, Kenji ;

Kodaira, Makoto ;

Fujikawa, Koshi ;

Sagawa, Tamotsu ;

Esaki, Taito ;

Shirakawa, Tsuyoshi ;

Hirai, Fumihiko ;

Yokoi, Yuki ;

Kawata, Toshio ;

Hatano, Ben ;

Takahashi, Yasuo .

CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2016, 78 (03) :525-531

[30] Safety and tolerability of the olaparib tablet formulation in Japanese patients with advanced solid tumours [J].

Kan Yonemori ;

Kenji Tamura ;

Makoto Kodaira ;

Koshi Fujikawa ;

Tamotsu Sagawa ;

Taito Esaki ;

Tsuyoshi Shirakawa ;

Fumihiko Hirai ;

Yuki Yokoi ;

Toshio Kawata ;

Ben Hatano ;

Yasuo Takahashi .

Cancer Chemotherapy and Pharmacology, 2016, 78 :525-531

← 1 2 3 4 5 →